benzoxazoles has been researched along with Mucositis, Oral in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobler, L; Faller, DV; Gupta, N; Kim, KP; Kuboki, Y; Lin, CC; Sedarati, F; Shimizu, T; Yanai, T; Yonemori, K | 1 |
1 trial(s) available for benzoxazoles and Mucositis, Oral
| Article | Year |
|---|---|
A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies.
Topics: Antineoplastic Agents; Benzoxazoles; Dose-Response Relationship, Drug; Humans; Maximum Tolerated Dose; Nausea; Neoplasms; Pyrazoles; Pyrimidines; Stomatitis | 2022 |